Shares of Boston Scientific Corp. BSX rose 1.57% to $95.05 Tuesday, on what proved to be an all-around positive trading ...

This was the stock's second consecutive day of losses.

Analysts expect Boston Scientific to report an earnings per share (EPS) of $0.67. Boston Scientific bulls will hope to hear ...

Tariff talk will continue in the second week of earnings season, but the updates could also shed light on trends and competitive dynamics in key markets.

Bearish flow noted in Boston Scientific (BSX) with 4,750 puts trading, or 1.6x expected. Most active are Sep-25 75 puts and 4/25 weekly 100 ...

Medical device company Boston Scientific (NYSE:BSX) will be reporting results tomorrow before market open. Here’s what to ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $118.54, a high ...

Boston Scientific (BSX) closed the most recent trading day at $95.12, moving -0.14% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.13%.

Needham upgraded Boston Scientific (BSX) to Buy from Hold with a $113 price target Needham’s latest electrophysiologist survey shows the ...

We recently published a list of 10 Best Low Volatility Stocks to Buy Now. In this article, we are going to take a look at ...

Needham & Company LLC upgraded shares of Boston Scientific (NYSE:BSX – Free Report) from a hold rating to a buy rating in a research report report published on Wednesday, Marketbeat Ratings reports.

Investing.com -- Needham upgraded Boston Scientific Corp (NYSE:BSX) to “Buy”, saying competition from pulsed field ablation (PFA) rivals looks less intense for its key product than it was earlier ...